Solid Biosciences Inc.
SLDB
$3.27
-$0.035-1.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -124.70M | -102.44M | -90.69M | -90.25M | -96.02M |
| Total Depreciation and Amortization | 2.46M | 2.18M | 2.36M | 2.23M | 2.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.38M | 10.86M | 6.36M | 6.80M | 8.12M |
| Change in Net Operating Assets | 2.85M | -1.79M | -3.41M | -10.16M | -8.87M |
| Cash from Operations | -100.01M | -91.19M | -85.38M | -91.38M | -94.18M |
| Capital Expenditure | -654.00K | -540.00K | -908.00K | -1.16M | -1.52M |
| Sale of Property, Plant, and Equipment | 5.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.44M | -8.82M | -22.10M | -64.90M | 11.20M |
| Cash from Investing | -16.09M | -9.36M | -23.01M | -66.06M | 9.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -473.00K | -345.00K | -225.00K | -- | -- |
| Issuance of Common Stock | 128.02M | 121.46M | 118.08M | 115.19M | 3.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.11M | -5.11M | -5.11M | -4.83M | -- |
| Cash from Financing | 122.44M | 116.00M | 112.75M | 110.36M | 3.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.34M | 15.46M | 4.36M | -47.08M | -81.37M |